Pharmaceutical firms Pfizer and Flynn Pharma have been accused by the Competition and Markets Authority, the UK's competition watchdog
of charging "excessive and unfair" prices for an anti-epilepsy drug. Phenytoin
sodium capsules, used by 50,000 people in Britain, are made by Pfizer and sold
by Flynn.
When Pfizer made the drug under its Epanutin brand name, the
NHS spent about £2.3m on the drug, the CMA said. This amount soared to £50m in
2013. The CMA said Pfizer sold UK distribution rights to Flynn in 2012, but
continued to make and supply the drug to the company. It was after this deal
that prices rose.
No comments:
Post a Comment